IL133709A0 - Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo - Google Patents

Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Info

Publication number
IL133709A0
IL133709A0 IL13370998A IL13370998A IL133709A0 IL 133709 A0 IL133709 A0 IL 133709A0 IL 13370998 A IL13370998 A IL 13370998A IL 13370998 A IL13370998 A IL 13370998A IL 133709 A0 IL133709 A0 IL 133709A0
Authority
IL
Israel
Prior art keywords
electrotransfer
tissues
vivo
optimized
nucleic acid
Prior art date
Application number
IL13370998A
Original Assignee
Rhone Poulence Rorer S A
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708232A external-priority patent/FR2765241B1/en
Priority claimed from FR9708233A external-priority patent/FR2765242B1/en
Application filed by Rhone Poulence Rorer S A, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulence Rorer S A
Publication of IL133709A0 publication Critical patent/IL133709A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
IL13370998A 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo IL133709A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708232A FR2765241B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF NUCLEIC ACID TRANSFER IN CELLS OF PLURICELLULAR EUKARYOTIC ORGANISMS AND COMBINATION FOR CARRYING OUT THE METHOD
FR9708233A FR2765242B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF THE TRANSFER OF NUCLEIC ACID IN THE STRIKE MUSCLE AND COMBINATION ALLOWING THE IMPLEMENTATION OF THE PROCESS
US6748897P 1997-12-01 1997-12-01
US6748797P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Publications (1)

Publication Number Publication Date
IL133709A0 true IL133709A0 (en) 2001-04-30

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13370998A IL133709A0 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Country Status (11)

Country Link
EP (1) EP0993318A1 (en)
JP (1) JP2002515816A (en)
KR (1) KR20010014298A (en)
CN (1) CN1261812A (en)
AU (1) AU8730798A (en)
BR (1) BR9810500A (en)
CA (1) CA2295029A1 (en)
IL (1) IL133709A0 (en)
NO (1) NO996540L (en)
PL (1) PL337617A1 (en)
WO (1) WO1999001175A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
CA2361601A1 (en) * 1999-02-08 2000-08-10 Cheryl Goldbeck Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
US7223395B2 (en) 2000-03-13 2007-05-29 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2
AU5345901A (en) 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
WO2001089455A2 (en) 2000-05-22 2001-11-29 Merck & Company, Inc. System and method for assessing the performance of a pharmaceutical agent delivery system
KR20030074680A (en) 2000-12-28 2003-09-19 와이어쓰 Recombinant protective protein from $i(streptococcus pneumoniae)
DE60234475D1 (en) 2001-03-02 2009-12-31 Univ Rockefeller RECOMBINANT HYBRID ALLERGENIC CONSTRUCTS WITH REDUCED ALLERGENITY, MAINTAINING THE IMMUNOGENICITY OF NATURAL ALLERGEN
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
EP1480692A2 (en) 2002-03-07 2004-12-01 Merck & Co., Inc. Clinical syringe with electrical stimulation aspects
PL210412B1 (en) 2002-05-24 2012-01-31 Schering Corp Neutralizing human anti-igfr antibody
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (en) * 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfer of nucleic acid into tissue cells
DK1933937T3 (en) * 2005-10-03 2015-04-07 Novocure Ltd OPTIMIZATION OF THE CHARACTERISTICS OF AN ELECTRIC FIELD FOR ENHANCING FIELD EFFECT ON proliferating cells
JP4961137B2 (en) * 2005-12-14 2012-06-27 久光製薬株式会社 Device for iontophoresis
AU2007319604B2 (en) 2006-10-19 2011-03-24 Csl Limited High affinity antibody antagonists of interleukin-13 receptor alpha 1
PL2068922T3 (en) 2006-10-19 2012-11-30 Csl Ltd Anti-il-13r alpha 1 antibodies and their uses thereof
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp POLINUCLEOTIDE VECTOR THAT INCLUDES IT RECOMBINATING CELL THAT UNDERSTANDS THE VECTOR POLYPEPTIDE, ANTIBODY, COMPOSITION THAT UNDERSTANDS THE POLINUCLEOTIDE, VECTOR, RECOMBINATING CELL POLYPEPTIDE OR ANTIBODY, USE OF THE COMPOSITION AND A COMPOSITION AND A METHOD
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
WO2010009252A1 (en) * 2008-07-18 2010-01-21 Maxcyte, Inc. Methods for optimizing electroporation
RU2478396C2 (en) 2008-11-05 2013-04-10 ВАЙЕТ ЭлЭлСи MULTI-COMPONENT IMMUNOGENIC COMPOSITION FOR PREVENTING DOSEASE, CAUSED BY β-HEMOLYTIC STREPTOCCOCI (BHS)
CA2808975C (en) 2010-08-23 2018-10-30 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
ES2864635T3 (en) 2010-09-10 2021-10-14 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
EP2822583A2 (en) 2012-03-09 2015-01-14 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (en) 2012-03-09 2017-04-12 فايزر انك Neisseria meningitidis compositions and methods thereof
WO2014107739A1 (en) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Antibodies against pcsk9
JP6446377B2 (en) 2013-03-08 2018-12-26 ファイザー・インク Immunogenic fusion polypeptide
CN105492021B (en) 2013-09-08 2018-12-04 辉瑞公司 Neisseria meningitidis composition and its method
MX2017010705A (en) 2015-02-19 2017-12-04 Pfizer Neisseria meningitidis compositions and methods thereof.
IL303108B1 (en) 2017-01-31 2024-03-01 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
WO1997007826A1 (en) * 1995-08-29 1997-03-06 Cbr Laboratories, Inc. In vivo electroporation of cells

Also Published As

Publication number Publication date
CA2295029A1 (en) 1999-01-14
EP0993318A1 (en) 2000-04-19
KR20010014298A (en) 2001-02-26
BR9810500A (en) 2000-09-05
NO996540L (en) 2000-02-03
PL337617A1 (en) 2000-08-28
WO1999001175A1 (en) 1999-01-14
AU8730798A (en) 1999-01-25
CN1261812A (en) 2000-08-02
NO996540D0 (en) 1999-12-29
JP2002515816A (en) 2002-05-28

Similar Documents

Publication Publication Date Title
IL133709A0 (en) Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
HUP0001261A3 (en) Method of imaging cell death in vivo
GB2331247B (en) Improvements in relation to apparatus for surgical diathermy
GB9713077D0 (en) Improvements relating to skin prickers
AP2000001762A0 (en) Method of delivering genes to antigen presenting cells of the skin
PL316200A1 (en) Co-ordinated expression of genes in vivo
GB9624165D0 (en) Use of nucleic acids bound to carrier macromolecules
PL325821A1 (en) Liquid acid netralising preparation
PL337942A1 (en) Isolated genes of dendricall cell membranic proteins
HUP0002683A3 (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
GB9708512D0 (en) Improvements relating to skin prickers
GB2346841B (en) Advantageous use of battery mass in electric watercraft
GB9515356D0 (en) Improvements in or relating to delivery of nucleic acid
GB9717932D0 (en) Estimation of nucleic acid
AU6894298A (en) Human fatty acid binding protein
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
GB2327815B (en) Terminal unit in which waterproof effect is improved
IL120466A0 (en) In vitro evolution of oligonucleotides
GB9705007D0 (en) Improvements in or relating to therapeutic genes
GB2369500B (en) Terminal unit in which waterproof effect is improved
TW444691U (en) Improved structure of car power connector
GB9928530D0 (en) Constructs for delivery of therapeutic agents to neuronal cells
GB9700699D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711839D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711845D0 (en) Improvements in or relating to diagnostic/therapeutic agents